CardioGenics Holdings Inc (CGNH)
USD 0.0
(9900.0%)
USD 0.0
(9900.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2015 | -757.37 Thousand USD | 91.82% |
| 2014 | -952.4 Thousand USD | 52.85% |
| 2013 | -2.3 Million USD | -83.36% |
| 2012 | -1.26 Million USD | 64.69% |
| 2011 | -5.56 Million USD | -116.76% |
| 2010 | -2.06 Million USD | -107.55% |
| 2009 | -28.32 Million USD | 2223.16% |
| 2008 | -1.02 Million USD | -112.8% |
| 2007 | -521.91 Thousand USD | 630.35% |
| 2006 | -2.28 Million USD | 3.01% |
| 2005 | -1.6 Million USD | 12.12% |
| 2004 | -1.77 Million USD | 7.01% |
| 2003 | -1.9 Million USD | 27.13% |
| 2002 | -2.87 Million USD | 46.56% |
| 2001 | -5.19 Million USD | 31.06% |
| 2000 | -14.5 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2016 Q1 | -399.48 Thousand USD | -18.82% |
| 2015 Q4 | -336.2 Thousand USD | -218.21% |
| 2015 FY | - USD | 91.82% |
| 2015 Q1 | -201.33 Thousand USD | 71.43% |
| 2015 Q2 | -531.83 Thousand USD | -164.16% |
| 2015 Q3 | 284.41 Thousand USD | 153.48% |
| 2014 FY | - USD | 52.85% |
| 2014 Q3 | 32.92 Thousand USD | 115.7% |
| 2014 Q4 | -704.6 Thousand USD | -2240.17% |
| 2014 Q1 | -257.7 Thousand USD | 86.06% |
| 2014 Q2 | -209.71 Thousand USD | 18.62% |
| 2013 Q4 | -1.84 Million USD | -667.22% |
| 2013 FY | - USD | -83.36% |
| 2013 Q3 | -240.87 Thousand USD | -18.75% |
| 2013 Q2 | -202.85 Thousand USD | 6.16% |
| 2013 Q1 | -216.17 Thousand USD | 27.92% |
| 2012 Q1 | -350.43 Thousand USD | 31.98% |
| 2012 Q4 | -299.91 Thousand USD | -30.68% |
| 2012 FY | - USD | 64.69% |
| 2012 Q3 | -229.49 Thousand USD | 39.25% |
| 2012 Q2 | -377.78 Thousand USD | -7.8% |
| 2011 FY | - USD | -116.76% |
| 2011 Q1 | -415.2 Thousand USD | -29.91% |
| 2011 Q2 | -526.85 Thousand USD | -26.89% |
| 2011 Q4 | -515.16 Thousand USD | 76.15% |
| 2011 Q3 | -2.15 Million USD | -309.94% |
| 2010 Q3 | -663.3 Thousand USD | -160.12% |
| 2010 FY | - USD | -107.55% |
| 2010 Q2 | -255 Thousand USD | 37.05% |
| 2010 Q1 | -405.09 Thousand USD | -103.03% |
| 2010 Q4 | -319.61 Thousand USD | 51.81% |
| 2009 Q1 | -423.8 Thousand USD | -98.48% |
| 2009 FY | - USD | 2223.16% |
| 2009 Q4 | 13.38 Million USD | 57.8% |
| 2009 Q2 | -115.25 Thousand USD | 72.81% |
| 2009 Q3 | 8.48 Million USD | 7460.19% |
| 2008 Q3 | -212.75 Thousand USD | 55.5% |
| 2008 Q1 | 1.81 Million USD | 184.44% |
| 2008 FY | - USD | -112.8% |
| 2008 Q4 | -213.52 Thousand USD | -0.36% |
| 2008 Q2 | -478.13 Thousand USD | -126.4% |
| 2007 FY | - USD | 630.35% |
| 2007 Q4 | -2.14 Million USD | -138.72% |
| 2007 Q3 | 5.53 Million USD | 5119.67% |
| 2007 Q2 | 106.11 Thousand USD | -96.41% |
| 2007 Q1 | 2.95 Million USD | 596.05% |
| 2006 Q4 | -595.34 Thousand USD | -30.39% |
| 2006 Q3 | -456.56 Thousand USD | 30.62% |
| 2006 Q2 | -658.04 Thousand USD | -5.73% |
| 2006 Q1 | -622.36 Thousand USD | -28.48% |
| 2006 FY | - USD | 3.01% |
| 2005 Q1 | -544.77 Thousand USD | -172.87% |
| 2005 FY | - USD | 12.12% |
| 2005 Q4 | -484.39 Thousand USD | -55.04% |
| 2005 Q3 | -312.43 Thousand USD | 37.4% |
| 2005 Q2 | -499.13 Thousand USD | 8.38% |
| 2004 Q2 | -682.59 Thousand USD | -257.47% |
| 2004 FY | - USD | 7.01% |
| 2004 Q4 | -199.64 Thousand USD | 58.42% |
| 2004 Q1 | -190.95 Thousand USD | 53.78% |
| 2004 Q3 | -480.13 Thousand USD | 29.66% |
| 2003 Q1 | -438.89 Thousand USD | -20.44% |
| 2003 Q4 | -413.12 Thousand USD | -24.53% |
| 2003 FY | - USD | 27.13% |
| 2003 Q3 | -331.75 Thousand USD | 56.85% |
| 2003 Q2 | -768.78 Thousand USD | -75.16% |
| 2002 Q3 | -627.75 Thousand USD | 18.95% |
| 2002 Q2 | -774.54 Thousand USD | 12.09% |
| 2002 Q1 | -1.14 Million USD | -167.52% |
| 2002 FY | - USD | 46.56% |
| 2002 Q4 | -364.41 Thousand USD | 41.95% |
| 2001 FY | - USD | 31.06% |
| 2001 Q3 | 1.13 Million USD | 120.18% |
| 2001 Q2 | 6.42 Million USD | 56.8% |
| 2001 Q1 | -2.83 Million USD | 23.91% |
| 2001 Q4 | -329.34 Thousand USD | -303.7% |
| 2000 Q1 | -3.02 Million USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q4 | -2.67 Million USD | 13.54% |
| 2000 Q2 | -4.48 Million USD | 5.57% |
| 2000 Q3 | -2.81 Million USD | 4.06% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | 34.877% |
| Arrayit Corporation | -3.07 Million USD | 75.39% |
| Atlantic International Corp. | -5.38 Million USD | 85.947% |
| Biocept, Inc. | -30.24 Million USD | 97.496% |
| Bioqual, Inc. | 3.03 Million USD | 124.977% |
| DermTech, Inc. | -97.89 Million USD | 99.226% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 100.026% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 96.258% |
| iMD Companies, Inc. | -154.65 Thousand USD | -389.706% |
| IDenta Corp. | 71.58 Thousand USD | 1157.978% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 119.739% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 2057.547% |
| InVitro International | 6680.00 USD | 11437.949% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | 86.067% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | -6141.759% |
| Medical Imaging Corp. | -896.74 Thousand USD | 15.541% |
| NovelStem International Corp. | -3.78 Million USD | 79.994% |
| Optigenex Inc. | -1.18 Million USD | 36.179% |
| PharmChem, Inc. | 1.05 Million USD | 171.87% |
| Proteome Sciences plc | -1.13 Million USD | 33.388% |
| Response Genetics, Inc | -19.66 Million USD | 96.149% |
| Rennova Health, Inc. | -234.81 Thousand USD | -222.541% |
| RushNet, Inc. | -614.85 Thousand USD | -23.18% |
| ScreenPro Security Inc. | -3.43 Million USD | 77.951% |
| Stella Diagnostics Inc. | -5.7 Million USD | 86.73% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | 92.625% |
| Todos Medical Ltd. | -9.39 Million USD | 91.938% |